U.S. Professional Services Stock News

In the past week, Service Corporation International outlined long-term growth opportunities at a Bank of America conference, while an analyst reiterated a positive outlook supported by third-quarter 2025 results that exceeded Wall Street expectations and a higher quarterly cash dividend. At the same time, insider share sales and management’s emphasis on future funeral volume growth from an aging baby boomer population highlighted both confidence in current performance and the importance of...

In October 2025, Equity Residential reported third-quarter results that largely met expectations, with revenue rising 4.6% year over year and funds from operations per share in line, but it cut its fiscal 2025 outlook due to softer leasing demand and delays in rolling out new income-generating initiatives. This combination of steady recent performance and a weaker forward outlook, particularly in markets like Washington, D.C., raises fresh questions about how resilient Equity Residential’s...

Mendon Capital Advisors just disclosed a fresh stake in Simmons First National (SFNC), picking up more than 400,000 shares. This represents a clear vote of confidence from a specialist in U.S. regional banks. See our latest analysis for Simmons First National. The Mendon move lands just as sentiment is starting to turn, with the share price at $19.65 and a 1 month share price return of 8.56 percent helping to offset a weak year to date share price return and a negative 1 year total...

Saia (SAIA) has quickly moved back onto investors radar after two things hit at once: fresh operating metrics for early Q4 and a reaffirmed positive stance from a major Wall Street bank. See our latest analysis for Saia. The latest operating update and upbeat stance from JPMorgan appear to have re-energised sentiment, with a roughly 24% 1 month share price return helping Saia claw back part of this year’s drawdown. This comes even though the 1 year total shareholder return remains negative,...

4D Advisors, LLC recently disclosed a new position in U.S. Physical Therapy, purchasing 110,000 shares worth over US$9,000,000 and making the stock its third-largest holding. This move by 4D Advisors highlights growing institutional interest in U.S. Physical Therapy’s role as a scale player in a fragmented rehabilitation market. We’ll now explore how 4D Advisors’ sizable new stake could influence U.S. Physical Therapy’s investment narrative and perceived growth runway. Trump's oil boom is...

VistaPrint, a Cimpress business, recently appointed Dave DeSandre as Senior Vice President of North America, Category Management, effective December 1, 2025, adding over two decades of industry experience and executive leadership from Wayfair. Investors may view his customer-centric track record in scaling Wayfair’s B2B platform as a meaningful reinforcement of VistaPrint’s push into higher-value, innovation-driven product categories and improved commercial execution. We’ll now examine how...

In recent months, Select Medical Holdings extended its common share repurchase program through December 31, 2027, authorizing up to US$1.00 billion while also reporting revenue growth across its critical illness recovery hospital, rehabilitation hospital, and outpatient rehabilitation segments in Q3 2025. This combination of an enlarged buyback commitment and broad-based revenue gains has reinforced views about the company’s financial flexibility and business momentum. With the expanded...

Earlier this week, Barclays initiated coverage on LifeStance Health Group with an Overweight rating, adding to recent favorable opinions from BMO Capital and UBS and signaling growing institutional attention on the outpatient mental health provider. This cluster of supportive analyst views highlights how LifeStance’s positioning in technology-enabled behavioral healthcare is increasingly attracting interest across Wall Street research desks. With Barclays’ positive initiation adding to this...

Recent commentary highlighted that Silgan Holdings, a long-time consolidator in the U.S. rigid packaging industry, is benefiting from strong free cash flow and disciplined capital allocation, including acquisitions and opportunistic share repurchases that have lifted its closures segment to over half of company EBITDA. An interesting angle for investors is how Silgan’s history of 41 acquisitions over 37 years underpins its ability to reinvest cash for growth while gradually reducing...

Energizer Holdings (ENR) just released its Q4 2025 results, and the story is a mixed bag, with higher net sales from acquisitions but weaker earnings after impairment charges and debt payoff losses affected the bottom line. See our latest analysis for Energizer Holdings. At around $19.43, Energizer Holdings has bounced in the last week with a 1 week share price return of 4.63 percent. However, the 1 year total shareholder return of negative 44.42 percent shows longer term momentum is still...

Earlier this week, Stagwell launched NewVoices.ai, a lifelike, multilingual AI platform that acts as an end-to-end independent sales and customer engagement agent for enterprises, operating 24/7 and integrating directly into clients’ revenue and service workflows. The platform’s emphasis on one-to-one personalization, continuous learning, and deployment across sales, support, renewals, payments, and feedback could deepen Stagwell’s higher-margin, software-like revenue streams. We’ll now...

Veris Residential (VRE) has been drifting lower this year, and that slide is catching value investors attention. With the stock down double digits year to date, the question is whether fundamentals justify the discount. See our latest analysis for Veris Residential. The recent slide caps a choppy year for Veris Residential, with the share price now at $14.57 and a negative year to date share price return, while the five year total shareholder return remains positive. This suggests sentiment...

Wondering if Celcuity at around $101 a share is still a smart buy after its huge run, or if you are late to the party? This breakdown will help you decide whether the current price matches the underlying value. The stock has climbed 1.8% over the last week, 32.8% in the last month, and an eye catching 675.6% year to date. Its 1 year gain of 692.5% and 3 year return of 881.0% show just how dramatically market expectations have shifted. Recent news flow around Celcuity has centered on growing...

MetLife (MET) has quietly outperformed the broader insurance group in recent sessions, with shares drifting higher as investors weigh its steady earnings growth, capital return profile, and how fairly the stock is currently priced. See our latest analysis for MetLife. That steady climb to around $79.82 comes after a patchy year for the share price, with short term share price returns recently turning positive even as the one year total shareholder return still hovers slightly negative. This...

If you are wondering whether Shopify is still worth buying after its huge run, or if the easy money has already been made, you are not the only one trying to figure out whether the current price makes sense. Over the last week the stock is up 3.8%. It has climbed 6.0% in the last month, 56.6% year to date, and 46.1% over the past year, while sitting around a recent close of $168.42. These gains have been supported by ongoing headlines around Shopify expanding its ecosystem, from partnerships...

If you are wondering whether Wayfair’s sharp comeback makes it a bargain or a trap at today’s price, you are not alone. This article is designed to help you cut through the noise. The stock has pulled back about 2% over the last week and roughly 17.1% over the last month, but it is still up an eye catching 102.6% year to date and about 69.9% over the past year. This highlights both strong momentum and elevated risk. Recent headlines have focused on Wayfair’s push to streamline operations and...

Arcutis Biotherapeutics (ARQT) has quietly put up an impressive run this year, with the stock more than doubling as investors warm to its dermatology pipeline, revenue growth, and improving path toward profitability. See our latest analysis for Arcutis Biotherapeutics. That move has not been a straight line, but the recent 30 day share price return of 25.35 percent and 90 day share price return of 68.29 percent, alongside a 1 year total shareholder return of 133.12 percent, shows momentum is...

Earlier this week, Upwork announced two new partnerships: one with embedded finance provider YouLend to offer on-platform financing to U.S. freelancers, agencies and small businesses, and another with OpenAI to help businesses more easily find talent with specific AI skills. Together, these agreements expand Upwork’s role from a pure talent marketplace into a broader work infrastructure platform, tying access to capital and AI-focused hiring more tightly into its ecosystem. We’ll now examine...

Benchmark Electronics (BHE) has reshuffled its leadership team, appointing David L. Cummings as Senior Vice President and Chief Commercial Officer, while David Moezidis steps into the role of President in preparation for an eventual transition to CEO. See our latest analysis for Benchmark Electronics. The leadership reshuffle lands at a time when momentum is already picking up, with a 90 day share price return of 22.59 percent and a three year total shareholder return of 82.40 percent...

Champion Homes (SKY) just turned in another quietly impressive quarter, and the market is starting to notice. Strong sales, higher earnings, and hefty buybacks, plus fresh institutional interest, are giving the stock new momentum. See our latest analysis for Champion Homes. The recent executive transition at the finance helm and fresh institutional buying are landing just as momentum improves, with a 90 day share price return of 17.22% and a five year total shareholder return of 179.92%,...

Recently, commentary around ePlus (NASDAQ:PLUS) highlighted that its sales have been flat for the past two years and are projected to fall over the next 12 months as demand for its IT solutions fades. This shift in demand expectations raises questions about the durability of ePlus’s business model and its ability to sustain prior operating trends. We’ll now explore how weakening demand and expectations for declining sales could reshape ePlus’s existing investment narrative. These 10...

Recent commentary on Labcorp Holdings has highlighted persistently slow organic sales growth, declining adjusted operating margins, and a weaker return on invested capital, raising fresh concerns about its core laboratory and drug development operations. These trends suggest Labcorp may need to rethink its cost base and capital allocation, as investors question whether the company is still finding enough high-quality, profitable growth opportunities. Next, we’ll examine how concerns over...

Cushman & Wakefield (CWK) just moved to voluntarily deregister its ordinary shares with the SEC and pulled a related shelf registration, a regulatory pivot that immediately puts stock liquidity and future capital raising under the microscope. See our latest analysis for Cushman & Wakefield. The deregistration move comes after a busy stretch of Investor Day strategy updates, M&A comments and major client wins. It also lands while the share price sits at $15.24 with a solid year to date share...

Wondering if PROS Holdings at around $23 is a quietly mispriced opportunity or a value trap in disguise? You are not alone. This stock often flies under the radar despite operating in a high-potential niche of AI powered pricing and revenue optimization software. Over the last month the share price has inched up about 0.5%, contributing to an 8.2% gain year to date. However, that is still set against a rough 5 year journey that has left the stock down more than 50% from its earlier...